¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Low vision, one eye"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • deviating eye
    »ç½Ã¾È, ÆíÀ§¾È
  • doll¡¯s eye reflex
    ÀÎÇü´«¹Ý»ç
  • doll¡¯s eye sign
    ÀÎÇü´«Â¡ÈÄ
  • dominant eye
    ¿ì¼¼¾È
  • eye
    ´«
  • eye bank
    ¾È±¸ÀºÇà, ´«ÀºÇà
  • eye dominance
    ´«¿ì¼¼, ¾È¿ì¼¼(¼º)
  • eye drop
    Á¡¾È¾à
  • eye glasses
    ¾È°æ
  • eye lotion
    Á¡¾È¾à
  • eye memory
    ½Ã°¢±â¾ï
  • eye patch
    ´«°¡¸², ¾È´ë
  • eye shield
    ´«º¸È£±¸
  • eye socket
    ´«È®, ¾È¿Í
  • eye spot
    ´«Á¡
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • dominant eye
    ¿ì¼¼¾È
  • dry eye
    ¸¶¸¥´«, ´«¸¶¸§Áõ
  • dry eye syndrome
    ´«¸¶¸§ÁõÈıº, ¸¶¸¥´«ÁõÈıº
  • eye drop
    Á¡¾È¾à
  • eye
    ´«, ¾È±¸
  • eye lotion
    Á¡¾È¾à
  • eye memory
    (¢¡visual memory) ½Ã°¢±â¾ï
  • eye patch
    ´«°¡¸², ¾È´ë
  • eye shield
    ´«º¸È£±¸
  • eye socket
    (¢¡orbit) ´«È®, ¾È¿Í
  • eye spot
    ´«Á¡
  • eye strain
    ´«ÇÇ·Î
  • eye tooth
    À§¼Û°÷´Ï, »ó¾Ç°ßÄ¡
  • eye tracking test
    ½ÃÇ¥ÃßÀû°Ë»ç, ½ÃÇ¥ÃßÀû°Ë»ç
  • fellow eye
    ´Ù¸¥´«
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • rod vision
    °£Ã¼½Ã(¡­ãÊ)
  • rod vision
    °£Ã¼½Ã°¢(¡­ãÊÊÆ).
  • scotopic vision
    ¾Ï¼Ò½Ã
  • scotopic vision
    ¹ã´«º¸±â, ¾Ï¼Ò½Ã(äÞá¶ãÊ).
  • sense of vision
    ½Ã°¢(ãÊÊÆ).
  • single binocular vision
    ¾ç¾È´ÜÀϽÃ
  • single vision
    ´ÜÀϽÃ(Ó¤ìéãÊ).
  • solid vision
    ÀÔü½Ã(í¡ô÷ãÊ).
  • stereoscopic vision
    ÀÔü½Ã
  • trichromatic vision
    »ï»ö½Ã
  • tubular vision
    °ü¸ð¾ç½Ã¾ß, °ü»ó½Ã¾ß
  • tunnel vision
    ÅͳνÃ(~ãÊ).
  • vision
    ½Ã°¢(ãÊÊÆ)
  • vision
    ½Ã°¢, ½Ã·Â
  • vision
    ½Ã°¢(ãÊÊÆ).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
DV dependent variable; diagnostic variable; difference in volume; digital vibration; dilute volume; dis...
DVIU direct-vision internal urethrotomy
Nv naked vision
PULHEMS physique, upper extremity, lower extremity, hearing and ears, eyes and vision, mental capacity, emot...
PVL perivalvular leakage; permanent vision loss
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
EM Eye movement
EM Eye muscle
ETD Eye tracking dysfunction
FED Fish Eye disease
FEF Frontal eye field
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • eye patch
    ¾È´ë
  • eye protection
    ´« º¸È£
  • eye rupture
    ¾È±¸ ÆÄ¿­
  • eye speculum
    °³°Ë±â
  • eye strain
    ´« ÇÇ·Î, ¾ÈÁ¤ ÇÇ·Î
  • eye tearing
    ´«¹° È긲
  • eye washes
    ¼¼¾È ¾à
  • lateral angle of eye
    °¡ÂÊ ´« ±¸¼®
  • left eye
    ¿Þ´«, Á¾È, ¿ÞÂÊ ´«
  • mid-eye
    Áß¾Ó ¾È
  • paralysis of the eye muscle
    ¾È¸é ¸¶ºñ
    ¾È±ÙÀÌ ¸¶ºñµÇ¾î ´«ÀÇ ¿îµ¿ÀÌ Á¦ÇѵǴ Áõ¼¼. ´«ÀÇ ¿îµ¿Àº 6°³ÀÇ ¿Ü¾È±Ù¿¡ ÀÇÇÏ¿© ÀÌ·ç¾îÁö°í ÀÖÀ¸¸ç, ÀÌµé ±ÙÀº ÀÏÁ¤ÇÑ ±äÀå »óŸ¦ Ç×»ó À¯ÁöÇϰí Àֱ⠶§¹®¿¡ ´«ÀÌ Á¤»ó À§Ä¡¸¦ À¯ÁöÇϰí ÀÖ´Â ¼ÀÀÌ´Ù. ±×·¯³ª ÀÌµé ±ÙÀÌ ¸¶ºñµÇ¸é ¾È±¸ ¿îµ¿ÀÇ Á¦ÇÑ, º¹½Ã, ¸¶ºñ¼º »ç½Ã, Çö±âÁõ, À§Ä¡ÀÇ ¿ÀÀÎ, µÎºÎÀÇ °æ»ç µîÀÌ Áõ¼¼·Î ³ªÅ¸³­´Ù. À̵é Áõ¼¼ÀÇ ´ëºÎºÐÀº º¹½Ã¸¦ °¡±ÞÀû Àû°Ô Çϱâ À§Çؼ­ ÀϾ´Â °ÍÀÌ´Ù. ¾È±Ù ¸¶ºñÀÇ Á¾·ù´Â ³úÀúÀÇ º´º¯¿¡ ÀÇÇÏ¿© ÀϾ´Â °æ¿ì°¡ ¸¹±â ¶§¹®¿¡ ¿ÜÀ̱٠¸¶ºñ, µ¿¾È ½Å°æ ¸¶ºñ, »ó»ç±Ù ¸¶ºñÀÇ ÇüÀ» ÃëÇÏ´Â ÀÏÀÌ ¸¹´Ù. ¿øÀÎÀº ºÒ¸íÇÑ °ÍÀÌ ÀûÁö ¾ÊÁö¸¸, ³úÀúÀÇ ¸Åµ¶, ¿°Áõ, Á¾¾ç, ÃâÇ÷, °ñÀý, ³úÀÇ ¿°Áõ, Á¾¾ç, ÃâÇ÷, ¿¬È­, ¾È¿ÍÀÇ ¿°Áõ, Á¾¾ç, ÃâÇ÷ ¹× ¿Ü»ó µîÀ» »ý°¢ÇÒ ¼ö ÀÖ´Ù. Ä¡·á¹ýÀº ¿øÀÎ ¿ä¹ýÀÌ °¡Àå ÁÁ°í, ¿øÀÎ ºÒ¸íÀÏ ¶§´Â ºñŸ¹ÎÁ¦, »ì¸®½Ç»êÁ¦, ¿ä¿ÀµåÁ¦ µîÀÌ ¾²ÀÌÁö¸¸, Àß ³´Áö ¾Ê´Â °æ¿ì°¡ ¸¹´Ù.
  • pink eye
    ºÐÈ«»ö ´«, ÃæÇ÷ ¾È
  • pseudophakic eye
    Àΰø ¼öÁ¤Ã¼ ¾È, ¾È³» ·»Áî ¾È, ¾È³» ·»Áî »ðÀÔ ¾È
  • rapid eye movement sleep
    ½Å¼Ó ¾È±¸¿îµ¿ ¼ö¸é, REM ¼ö¸é
    ½É¹Úµ¿, È£Èí ¼ö, Ç÷¾ÐÀÇ ½ÉÇÑ Áõ°¡, ±×¸®°í ºü¸¥ ¾È±¸ ¿îµ¿ ±â°£, ±Ù¿¬Ãà
  • Snellen's reform eye
    ½º³Ú·» °³Á¶¾È
    ¿äöÀÇ À¯¸®ÆÇ 2¸Å¸¦ Á¶ÇÕÇÑ °ÍÀ¸·Î¼­, ±× Áß°£Àº °ø±ØÀ¸·Î µÇ¾î ÀÖ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
low-activation materials <radiobiology> In fission reactors, one is forced to deal with the radioactive byproducts of the fission process, but in fusion reactors one generally has a choice of what materials to expose to neutrons produced by the fusion process. A major problem for fusion reactors is developing materials (such as for the reactor vacuum vessel structure) which can be exposed to high levels of neutron bombardment without becoming permanently radioactive. Candidate structural materials which have relatively low induced radiactivation (generally relative to stainless steel) are known as low-activation materials, these include titanium, vanadium, and silicon-carbide.
(09 Oct 1997)
low affinity platelet factor IV Cytokine, produced from platelet basic protein, that acts as a growth factor.
(18 Nov 1997)
low aspect ratio <physics> An aspect ratio for a torus that is small (minor radius is almost as big as major radius).
There are many fusion devices which are designed to have a low aspect ratio. Such devices look more like tractor tires than bicycle tires, as toruses go. There are reasons to believe that low aspect ratio devices will offer some advantages for a fusion reactor. Usually, ease of theoretical and/or numerical analysis is not one of these advantages.
(16 Mar 1998)
low back pain A continuous pain in the lower back or lumbar region.
(12 Dec 1998)
low-calorie diet A diet of 1,200 calories or less per day.
(05 Mar 2000)
low convex The segment of a sphere of long radius.
(05 Mar 2000)
low delirium Delirium in which there is little excitement, either mental or motor, the ideas being confused and incoherent, but following each other slowly.
(05 Mar 2000)
low density lipoprotein <biochemistry> A lipoprotein substances (combination of a fat and a protein) which acts as a carrier for cholesterol and fats in the bloodstream.
High levels of low density lipoprotein are considered a positive risk factor for the development of coronary artery disease. Less than 130 mg/dl is desirable, 130 to 159 mg/dl is borderline high, over 160 is considered high.
Acronym: LDL
(10 Jan 1998)
low density lipoprotein receptor <biochemistry> A cell surface protein that mediates the endocytosis of low density lipoprotein by cells.
Genetic defects in low density lipoprotein receptors lead to abnormal serum levels of low density lipoprotein and hypercholesterolaemia.
(16 Mar 1998)
low-density lipoprotein receptors Receptors on the surface of cells, especially liver cells, which bind to low density lipoprotein and promote clearance of LDL from the plasma.
(05 Mar 2000)
low-egg-passage vaccine See: rabies vaccine, Flury strain egg-passage.
(05 Mar 2000)
low-fat diet A diet containing minimal amounts of fat.Diets containing low amounts of fat and cholesterol are designed to reduce the risk of heart disease and, in some cases, cancer. Dozens of such diets have been promulgated, both by medical and lay advisors. Their popularity can be attributed in part to clinical studies that have, since the 1980s, revealed, on the one hand, the hazards of eating high-fat, high-cholesterol foods and, on the other, the benefits of ingesting less saturated fat and LDL (low density lipoprotein) cholesterol. Although coronary deaths have been reduced by roughly 30% since 1970, the aim of health officials is to further reduce heart attack rates. The average cholesterol level among adult Americans has fallen from 213 to 205 mg/dl since 1978. However, the National Cholesterol Education Program recommends that individuals maintain a total cholesterol level of no more than 200 mg/dl, with LDL at less than 130 mg/dl and HDL (high density lipoprotein) around 60 mg/dl. About one-half of American adults exceed those recommendations. Low-fat, low-cholesterol diets are rich in whole grains, fresh fruits and vegetables, and legumes, and limit or exclude consumption of processed oils, dairy products, nuts and seeds, and meats. See atherosclerosis, free radicals.
(05 Mar 2000)
low flow principle A principle based on the observation that animals can survive prolonged vena caval occlusion without sequelae: if blood from the azygos vein alone is permitted to enter the heart, patients are perfused during cardiac and pulmonary bypass at flows much less than the normal resting cardiac output.
Synonym: low flow principle.
(05 Mar 2000)
low forceps delivery Delivery by forceps applied to the foetal head after it is clearly visible, the skull has reached the perineal floor, and plus 2 (+2) station. This classification of forceps delivery may be with or without rotation of the foetal head.
(05 Mar 2000)
low frequency transduction Specialised transduction in which only a small portion of the prophage particles, because of their defectiveness, are able to develop sufficiently to serve as effective transducing agents.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • cross-eye
    ³»»ç½Ã;¸ðµé¶ß±â´«
  • eagle eye
    ³¯Ä«·Î¿î ´«;´«ÀÌ ³¯Ä«·Î¿î »ç¶÷;ŽÁ¤
  • electric eye
    ±¤ÀüÁö;±¤Àü°ü 
  • electric eye camers
    ÀÚµ¿ ³ëÃâ Ä«¸Þ¶ó
  • evil eye
    ¾ÇÀÇ¿¡ Âù ´«Ãʸ®
  • eye
    ´«;´«¸Å;½Ã·Â;ÁÖ¸ñ;¾È½Ä;º¸´Â´«;°ßÇØ;´« ¸ð¾çÀÇ °Í;ŽÁ¤;·¹ÀÌ´õ ¼ö»ó±â;Àß º¸´Ù;ÀÚ¼¼È÷ º¸´Ù
  • eye appeal
    »ç¶÷´«À»²ù;¸Å·Â
  • eye bank
    ¾È±¸ÀºÇà
  • eye bath
    (¿µ)=EYECUP
  • eye chart
    ½Ã·Â°Ë»çÇ¥
  • eye contact
    ½Ã¼±ÀÌ ¸¶ÁÖħ
  • eye dialect
    ½Ã°¢¿Í¾î(¹ßÀ½´ë·Î³¹¸»À»¾´°Í)
  • eye doctor
    (±¸)¾È°ú ÀÇ»ç;°Ë¾È»ç
  • eye drops
    ¾È¾à
  • eye lens
    ´ë¾È(Á¢¾È)·»Áî
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
ÅëÇÕ°Ë»ö ¿Ï·á